Adherium has now manufactured and sold 100,000 of its Smartinhaler inhaler monitoring devices, the company has announced. According to Adherium, the Smartinhaler has been sold in more than 40 countries to date.
The Smartinhaler platform received FDA 510(k) clearance in 2014 and is currently being used in the myAirCoach project in Europe. In 2015, Adherium announced that it had partnered with AstraZeneca to provide Smartinhaler sensors for use in asthma and COPD patient support programs.
Adherium CEO Arik Anderson said, “The sale of our 100,000th Smartinhaler shows that Adherium’s commercial roll-out is accelerating. It is one thing to design Smartinhalers, but a whole different matter to manufacture and sell this number of devices.”
